Announced Mon, 15 Jun · 17:33 IST
Gland Pharma: Director resigns over conflict of interest; new independent director appointed
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹2210.00
prior close
₹2218.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.7-0.1+0.3-0.5-0.5-0.6-1.1+3.4+4.7+13.1+15.2——
Up moveDown movePending
AI summary
Gland Pharma's board approved three changes: re-appointment of Udo J. Vetter as Independent Director for a second 5-year term starting July 21, 2026; appointment of William Robert Keller (currently on Wuxi Biologics board) as new Independent Director effective June 15, 2026; and acceptance of C.S.N. Murthy's resignation due to a potential future conflict of interest as his other company may enter a similar business segment. Board committees were realigned accordingly.
Likely market impact
Governance-positive: conflict-of-interest risk addressed proactively; new independent director brings 40+ years of global pharma experience.